Hostname: page-component-7d684dbfc8-jr2wd Total loading time: 0 Render date: 2023-09-22T02:06:21.329Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": true, "coreDisableEcommerce": false, "coreDisableSocialShare": false, "coreDisableEcommerceForArticlePurchase": false, "coreDisableEcommerceForBookPurchase": false, "coreDisableEcommerceForElementPurchase": false, "coreUseNewShare": true, "useRatesEcommerce": true } hasContentIssue false
  • English
  • Français

The use of Some New Pharmacological Agents in Psychiatry

Published online by Cambridge University Press:  08 February 2018

D. M. Leiberman  and
G. F. Vaughan
D. M. Leiberman
Affiliation:
Bexley Hospital, Kent
G. F. Vaughan
Affiliation:
Guy's Hospital, London; Wood Vale Children's Home
Get access Rights & Permissions [Opens in a new window]

Extract

The last five years have seen the beginning of a remarkable new development in the pharmacological approach to psychiatry. Pharmacological treatment for mental disorder is not, of course, new; drugs like hellebore, opium, camphor, bromides, paraldehyde and the barbiturates cover a large part of the history of psychiatric therapy. Since 1951 a number of new drugs with the generic title of tranquillizers have been introduced, of which the two best known are chlorpromazine and reserpine. They have the characteristic effect of producing sedation without producing sleep.

Type
Original Articles
Information
Journal of Mental Science , Volume 103 , Issue 430 , January 1957 , pp. 110 - 118
Copyright
Copyright © Royal College of Psychiatrists, 1957 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Avol, ML, and Vogel, P. J., J.A.M.A., 1955, 159, 1516.CrossRefGoogle Scholar
Bair, H. V., and Herold, W., Arch. Neurol. Psychiat., 1955, 74, 363.CrossRefGoogle Scholar
Barsa, J. A., and Kline, W. S., Arch. Neurol. Psychiat., 1955, 74, 280.CrossRefGoogle Scholar
Barsa, J. A., and Kline, N. S., Amer. J. Psychiat., 1956, 112, 684.CrossRefGoogle Scholar
Bein, H. J., Gross, F., Tripod, J., and Meier, R., Schweiz. Med. Wschr., 1953, 83, 1007.Google Scholar
Burn, J. H., Proc. Roy. Soc. Med., 1954, 47, 445.Google Scholar
Carey, E. F., Ann. N. Y. Acad. Sci., 1955, 61, 222.CrossRefGoogle Scholar
Courvoisier, S., Fournal, J., DUCROT, R., Kolsky, M., and Koetschet, P., Arch. Int. Pharmacodyn., 1953, 92, 305.Google Scholar
Davies, D. L., and Shepherd, M., Lancet, 1955, ii, 117.CrossRefGoogle Scholar
Dean, S. R., Amer. J. Psychiat., 1956, 112, 850.CrossRefGoogle Scholar
Elkes, J., Brit. med. J., 1956, i, 512.Google Scholar
Ferguson, J. T., Ann. N.Y. Acad. Sci., 1955, 61, 101.CrossRefGoogle Scholar
Folkson, A., and May, A. R., Brit. Med. J., 1955, ii, 1121.CrossRefGoogle Scholar
Gaddum, J. H., J. Physiol., 1953, 121, 15P.Google Scholar
Gatski, R. L., J.A.M.A., 1955, 157, 1298.CrossRefGoogle Scholar
Gellhorn, E., Physiological Foundations of Neurology and Psychiatry, 1953. Minneapolis.Google Scholar
Gyermek, L., Lancet, 1955, ii, 724.CrossRefGoogle Scholar
Himwich, H. E., J. nerv. Ment. Dis., 1955, 122, 413.CrossRefGoogle Scholar
Hoch, P. H., Arch. Neurol. Psychiat., 1956, 75, 325.Google Scholar
Hollister, L. E., Krieger, G. E., Kringal, A., and Roberts, R. H., Ann. N. Y. Acad. Sci., 1955, 61, 92.CrossRefGoogle Scholar
Horatz, K., Der Anaesthetist, 1954, 2, 193.Google Scholar
Idem , Munch. Med. Wschr., 1954, 96, 426.Google Scholar
Ingram, W. R., EEG Clin. Neurophysiol., 1952, 4, 397.CrossRefGoogle Scholar
Jasper, H. H., EEG Clin. Neurophysiol., 1949, 1, 405.CrossRefGoogle Scholar
Kinross-Wright, V., Ann. N.Y. Acad. Sci., 1955, 61, 174.CrossRefGoogle Scholar
Kline, N. S., and Stanley, A. M., Ann. N. Y. Acad. Sci., 1955, 61, 85.CrossRefGoogle Scholar
Kovitz, B., Carter, J. T., and Addison, W. P., Arch. Neurol. Psychiat., 1955, 74, 467.CrossRefGoogle Scholar
Leiberman, D. M., and Vaughan, G. F., Brit. Med. J., 1956, i, 512.Google Scholar
Lemere, F., Arch. Neurol. Psychiat., 1955, 74, 1.CrossRefGoogle Scholar
Moore, J. N. P., Brit. Med. J., 1956, i, 512.Google Scholar
Moruzzi, G., and Magoun, H. W., EEG Clin. Neurophysiol., 1949, 1, 455.CrossRefGoogle Scholar
Muller, J. C., Prior, W. W., Gibbons, J. E., and Orgain, E. S., J.A.M.A., 1955, 159, 836.CrossRefGoogle Scholar
Niescholz, O., Arzneimittelforschg., 1954, 4, 232.Google Scholar
Pond, D. A., Proc. Roy. Soc. Med., 1954, 47, 775.Google Scholar
Pletscher, A., Shore, P. A., and Brodie, B. B., J. Pharm. Exp. Ther., 1956, 116, 84.Google Scholar
Rinaldi, F., and Himwich, H. E., Dis. Nerv. Syst., 1955, 16, 133.Google Scholar
Rinaldi, F., Rudy, L. A., and Himwich, H. E., Amer. J. Psychiat., 1956, 112, 678.CrossRefGoogle Scholar
Roberts, R. H., Ann. N.Y. Acad. Sci., 1955, 61, 92.CrossRefGoogle Scholar
Sainz, A. A., Ann. N.Y. Acad. Sci., 1955, 61, 72.CrossRefGoogle Scholar
Sargant, W., Brit. Med. J., 1956, i, 939.CrossRefGoogle Scholar
Schroeder, H. A., and Perry, H. M., J.A.M.A., 1955, 159, 839.CrossRefGoogle Scholar
Smirk, F. H., Lancet, 1955, ii, 115.CrossRefGoogle Scholar
Sulman, F. G., and Winnick, H. Z., Lancet, 1956, i, 161.CrossRefGoogle Scholar
Vaughan, G. F., Leiberman, D. M., and Cook, L. C., Lancet, 1955, i, 1083.CrossRefGoogle Scholar
Watt, D., “Report on International Colloquium, Paris, 1955”, J. Canad. Med. Ass., 1955, 78, 989.Google Scholar
Weber, E., Schweiz. Med. Wschr., 1954, 84, 968.Google Scholar
Werenberg, H., Nordisk. Med., 1955, 54, 1787.Google Scholar
Zimmerman, F. T., and Burgemeister, B. B., Ann. N. Y. Acad. Sci., 1955, 61, 215.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.